We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
Turnover
17.35%
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
-6.5%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$239M
AUM Growth
-$14.3M
(-5.6%)
Cap. Flow
+$18M
Cap. Flow
% of AUM
7.56%
Top 10 Holdings %
Top 10 Hldgs %
75.03%
Holding
66
New
2
Increased
22
Reduced
19
Closed
3
Avg Time Held
1.8
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$15.5M |
| 2 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$2.43M |
| 3 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$1.67M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$714K |
| 5 |
Alerian MLP ETF
AMLP
|
+$650K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BIOMED REALTY TRUST INC
BMR
|
+$1.53M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$944K |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$450K |
| 4 |
Vanguard Energy ETF
VDE
|
+$377K |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$365K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.84% |
| 2 | Healthcare | 15.89% |
| 3 | Real Estate | 0.44% |
| 4 | Financials | 0.27% |
| 5 | Materials | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
WisdomTree US LargeCap Dividend Fund
DLN
$6.31B
| $276K | 0.12% |
7,520
| – | – |
2013 Q2
11 quarters
|
|
52
Illumina
ILMN
$40.5B
| $273K | 0.11% |
1,731
| – | – |
2014 Q1
8 quarters
|
|
|
SQNM
53
DELISTED
SEQUENOM INC NEW
SQNM
| $249K | 0.1% |
176,777
+300
| +0.2% | +$447 |
2013 Q3
10 quarters
|
|
54
iShares Russell 1000 ETF
IWB
$49.2B
| $246K | 0.1% |
+2,157
| New | +$233K |
2016 Q1
0 quarters
|
|
55
iShares Core S&P 500 ETF
IVV
$889B
| $211K | 0.09% |
1,020
| – | – |
2015 Q4
1 quarter
|
|
56
iShares MSCI Pacific ex Japan ETF
EPP
$2.21B
| $209K | 0.09% |
5,332
-476
| -8% | -$17.3K |
2013 Q2
11 quarters
|
|
57
DELISTED
Regulus Therapeutics
RGLS
| $198K | 0.08% |
238
| – | – |
2015 Q2
3 quarters
|
|
58
DELISTED
Assertio
ASRT
| $149K | 0.06% |
178
+11
| +7% | +$10.2K |
2014 Q2
7 quarters
|
|
59
Bank of America
BAC
$362B
| $135K | 0.06% |
10,009
-156
| -2% | -$2.11K |
2015 Q4
1 quarter
|
|
|
HNGR
60
DELISTED
Hanger Inc.
HNGR
| $135K | 0.06% |
20,836
| – | – |
2015 Q3
2 quarters
|
|
|
BIOC
61
DELISTED
Biocept, Inc.
BIOC
| $49K | 0.02% |
1
| – | – |
2015 Q1
4 quarters
|
|
|
APTO
62
DELISTED
Aptose Biosciences, Inc.
APTO
| $36K | 0.02% |
27
| – | – |
2015 Q4
1 quarter
|
|
63
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| – | – |
0
| – | – |
2014 Q2
7 quarters
|
|
64
Vanguard Information Technology ETF
VGT
$150B
| – | – |
-17,912
| Closed | -$242K | – |
|
|
65
Vanguard Morningstar Large-Cap ETF
VV
$54.8B
| – | – |
-10,095
| Closed | -$944K | – |
|
|
66
DELISTED
BIOMED REALTY TRUST INC
BMR
| – | – |
-64,584
| Closed | -$1.53M | – |
|
Similar funds
PRO
MBA
SIA
AP
MW
SBIA
LC
TW
Callan Capital's Q1 2016 Portfolio in Review
As of Q1 2016, Callan Capital held 66 positions worth $239M, down 5.6% from $253M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Callan Capital deployed $18M of net new capital in Q1 2016, opening 2 new positions and adding to 22 existing holdings. Its largest new stake was Agios Pharmaceuticals: 7,000 shares worth $284K.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 70% a quarter earlier, followed by Healthcare and Real Estate.
On the sell side, the largest reduction was Vanguard FTSE Europe ETF, an estimated $450K trimmed.
- Callan Capital's largest Q1 2016 buy was Agios Pharmaceuticals: 7,000 shares worth $284K.
- Callan Capital added most to Vanguard FTSE All-World ex-US ETF in Q1 2016, an estimated $15.5M increase.
- Callan Capital's biggest Q1 2016 reduction was Vanguard FTSE Europe ETF, cutting an estimated $450K.
- Callan Capital fully exited BIOMED REALTY TRUST INC in Q1 2016, selling an estimated $1.53M.
- Callan Capital's ten largest holdings make up 75% of its $239M portfolio in Q1 2016.
- Callan Capital opened 2 new positions and closed 3 in Q1 2016.
- Callan Capital's portfolio value fell 5.6% quarter-over-quarter to $239M.
Based on Callan Capital's 13F filing for Q1 2016, filed 11 May 2016.